Hyderabad-based vaccine pharmaceutical company, Biological E. Limited, on Monday announced that it has reduced the price of its COVID-19 vaccine, CORBEVAX, from 840 to 250 rupees a dose inclusive of GST, for Private Vaccination Centres. The company in a release said, the price will be 400 rupees a dose for the end user, including taxes and administration charges.
BE has lowered the price of its vaccine with the aim of making it more affordable and help increase the reach to protect the maximum number of children against the virus. The decision comes within weeks of Biological E. Limited receiving Emergency Use Authorization (EUA) for children between five and twelve years of age.
CORBEVAX is also offered in a single-dose vial, making it more convenient for vaccine administration. It eliminates vaccine wastage, which is a major advantage for private hospitals.
The CORBEVAX vaccination slot can be booked through the Co-WIN app or the Co-WIN portal for children aged 12 to 17 years. So far, 43.9 Million doses of CORBEVAX have been administered to children across the country and Biological E. Limited has supplied close to 100 Million doses to the Government of India.
